Fresh analysis suggests that individuals who discontinue blockbuster weight-loss injections like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who stop conventional lifestyle programs.
Research printed in a major medical journal demonstrates that while overweight people frequently drop substantial amounts of their body weight while undergoing treatment, the mass is regained at an average rate of nearly a kilo each month once they quit.
"Users buying these drugs must be informed of the danger of rapid rebound weight gain when the therapy is stopped," warns lead investigator Dr. Susan Jebb.
That rate of recovery suggests a reversion to original weight in about a year and a half.
Analyzing Approaches
The research, which reviewed dozens of studies involving thousands of patients, compared the results of these new drugs with conventional dieting.
The team note that individuals who lose weight through lifestyle changes alone usually see a slower weight regain—perhaps 0.1 kg a month—after stopping.
The Reason for the Fast Regain
Nutrition scientists suggest the mode of action of the injections is key to understanding the heightened rebound.
The injections mimic a natural hormone called GLP-1, which moderates appetite.
"Sustained high doses of GLP-1 levels several times higher than normal might result in the system to generate a reduced amount of its endogenous GLP-1, and could reduce sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement means appetite is no longer kept in check, making overeating a significant risk."
A Lifelong Condition?
Health authorities recommend the injections for people with obesity-related medical conditions, alongside prescribed lifestyle changes.
Professionals contend that, given the high risk of weight regain, the therapy is often ongoing.
This view is supported by drug manufacturers, who say that the findings "emphasize the chronic character of excess weight," akin to managing diseases like high blood pressure.
Patient Accounts
Users who have stopped the medication report a intense resurgence of hunger.
"It felt as if a switch flipping and I was suddenly starving," recalled one woman.
This challenge is exacerbated if patients have not adopted permanent dietary or behavioural modifications during therapy.
Widespread Use
Survey data suggest that millions of people in the UK have used weight-loss jabs in the past year, with demand remaining high.
- Adoption is greater among women than men.
- The middle-aged age group shows the greatest level of interest.
- A large proportion obtain the medications through private prescriptions rather than the NHS.
Ultimately, clinicians emphasize that while these medications are potent tools for weight loss, they are not a standalone solution and long-term success hinges on integrated lifestyle management.
